目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION
FIGURE 2 REGIONAL SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 38)
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY MARKET (2021)
FIGURE 7 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2021)
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 10 CAGR PROJECTIONS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.4 KEY INDUSTRY INSIGHTS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 STUDY ASSUMPTIONS
2.8 RECESSION IMPACT

3 EXECUTIVE SUMMARY (Page No. - 52)
FIGURE 12 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 13 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GLOBAL MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 57)
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
FIGURE 18 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
4.2 REGIONAL MIX: LATERAL FLOW ASSAY MARKET
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 ASIA PACIFIC: MARKET, BY APPLICATION AND COUNTRY (2021)
FIGURE 20 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.4 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH IN FORECAST PERIOD
4.5 GLOBAL MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
FIGURE 22 DEVELOPING COUNTRIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 61)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of infectious diseases
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)
5.2.1.2 Rapidly increasing geriatric population
FIGURE 24 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)
5.2.1.3 Growing use of home-based lateral flow assay devices
5.2.1.4 Growing demand for point-of-care testing
5.2.1.5 Need for rapid diagnostic testing for COVID-19
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent results of lateral flow assay tests
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry
5.2.3.3 Omicron offers growth opportunities for players in lateral flow assay market
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE FOR DETECTION OF OMICRON
5.2.4 CHALLENGES
5.2.4.1 Limited reimbursements for lateral flow assay products
5.2.4.2 Difficulties in procuring quality raw materials for development of lateral flow assay tests
5.3 COVID-19 IMPACT ASSESSMENT ON ECONOMIC SCENARIO
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.5 AVERAGE SELLING PRICE TREND
5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS AND REAGENTS)
5.5.2 AVERAGE SELLING PRICE TRENDS
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2021
5.6 ECOSYSTEM MARKET MAP
FIGURE 27 GLOBAL MARKET: ECOSYSTEM ANALYSIS (2021)
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN GLOBAL MARKET, 2016-2022
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016-2022
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN GLOBAL MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016-2022
5.8 VALUE CHAIN ANALYSIS
FIGURE 31 GLOBAL MARKET: VALUE CHAIN ANALYSIS (2021)
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
5.9.2 ADJACENT TECHNOLOGY: ENZYME-LINKED IMMUNOSORBENT ASSAYS
5.10 CASE STUDY ANALYSIS
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY LANDSCAPE
5.11.1.1 North America
5.11.1.2 Europe
5.11.1.3 Asia
5.11.1.3.1 India
5.11.1.3.2 China
5.11.1.3.3 Japan
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY BY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 GLOBAL MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 ADJACENT MARKET ANALYSIS
5.14 KEY CONFERENCES AND EVENTS DURING 2023-2024
TABLE 10 GLOBAL MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
5.15.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
5.16 TRADE ANALYSIS
5.17 INDUSTRY TRENDS
5.17.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS
TABLE 12 US: HIV PREVALENCE RATE, 2016-2020
5.17.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS
5.18 IMPACT OF INFLATION AND RECESSION ON GLOBAL MARKET

6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT (Page No. - 88)
6.1 INTRODUCTION
TABLE 13 LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
6.2 KITS AND REAGENTS
6.2.1 INCREASING DEMAND FOR POC TESTING TO DRIVE MARKET
TABLE 14 LATERAL FLOW KITS AND REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 LATERAL FLOW READERS
TABLE 15 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN MARKET
TABLE 16 LATERAL FLOW ASSAY KITS AND REAGENTS WITH AND WITHOUT ANALYZERS
TABLE 17 LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 18 LATERAL FLOW READERS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 19 LATERAL FLOW READERS MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 20 LATERAL FLOW READERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3.1 DIGITAL/HANDHELD READERS
6.3.1.1 Technological advancements and high accuracy—major factors driving market
TABLE 21 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 22 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION, 2020-2027 (THOUSAND UNITS)
6.3.2 BENCHTOP READERS
6.3.2.1 Lower diagnosis cost per patient to drive adoption
TABLE 23 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 24 BENCHTOP LATERAL FLOW READERS MARKET, BY REGION, 2020-2027 (THOUSAND UNITS)
6.4 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW READERS
6.5 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY TYPE
6.5.1 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS
TABLE 25 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS
FIGURE 34 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2021)

7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION (Page No. - 101)
7.1 INTRODUCTION
TABLE 26 LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
7.2 CLINICAL TESTING
TABLE 27 GLOBAL MARKET FOR CLINICAL TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 28 GLOBAL MARKET FOR CLINICAL TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1 INFECTIOUS DISEASE TESTING
TABLE 29 GLOBAL MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 30 GLOBAL MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.1 Mosquito-borne diseases
7.2.1.1.1 Increasing incidence of dengue to support market growth
TABLE 31 DENGUE TESTING PRODUCTS AVAILABLE IN MARKET
TABLE 32 GLOBAL MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.2 COVID-19
7.2.1.2.1 COVID-19 pandemic resulted in adoption of rapid lateral flow tests
TABLE 33 LATERAL FLOW ASSAY TESTS FOR COVID-19 (ANTIGEN AND ANTIBODY)
TABLE 34 GLOBAL MARKET FOR COVID-19, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.3 Influenza
7.2.1.3.1 Growing prevalence of influenza to support market growth
TABLE 35 GLOBAL MARKET FOR INFLUENZA, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4 Sexually transmitted infections
TABLE 36 LATERAL FLOW ASSAY MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 37 GLOBAL MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4.1 HIV
7.2.1.4.1.1 Growing awareness of HIV POC testing to drive market
TABLE 38 GLOBAL MARKET FOR HIV, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4.2 HPV
7.2.1.4.2.1 Rising adoption of HPV testing to drive market during forecast period
TABLE 39 GLOBAL MARKET FOR HPV, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4.3 Chlamydia
7.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients to drive market
TABLE 40 GLOBAL MARKET FOR CHLAMYDIA, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4.4 Gonorrhea
7.2.1.4.4.1 Rising incidence of gonorrhea and increased funding for R&D to support market growth
TABLE 41 GLOBAL MARKET FOR GONORRHEA, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4.5 Syphilis
7.2.1.4.5.1 Growing adoption of novel technologies to support market growth
TABLE 42 GLOBAL MARKET FOR SYPHILIS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.4.6 Other sexually transmitted infections
TABLE 43 GLOBAL MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.5 Hepatitis
7.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in hepatitis testing market
TABLE 44 GLOBAL MARKET FOR HEPATITIS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.6 Tuberculosis
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market
TABLE 45 LATERAL FLOW ASSAY MARKET FOR TUBERCULOSIS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.1.7 Other infectious diseases
TABLE 46 GLOBAL MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2 CARDIAC MARKER TESTING
TABLE 47 GLOBAL MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2.1 Troponin I and T
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market
TABLE 49 GLOBAL MARKET FOR TROPONIN I AND T TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2.2 CK-MB
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
TABLE 50 GLOBAL MARKET FOR CK-MB TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2.3 BNP and NT-proBNP
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to propel adoption
TABLE 51 GLOBAL MARKET FOR BNP AND NT-PROBNP TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
TABLE 52 GLOBAL MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2.5 D-dimer
7.2.2.5.1 Rising incidence of cardiovascular diseases to drive market for D-dimer tests
TABLE 53 GLOBAL MARKET FOR D-DIMER TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.2.6 Other cardiac markers
TABLE 54 GLOBAL MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.3 PREGNANCY AND FERTILITY TESTING
TABLE 55 GLOBAL MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 56 GLOBAL MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.3.1 Pregnancy testing
7.2.3.1.1 Most common application area for lateral flow assays
TABLE 57 GLOBAL MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.3.2 Fertility testing
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits
TABLE 58 LATERAL FLOW ASSAY MARKET FOR FERTILITY TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.4 CHOLESTEROL/LIPID TESTING
7.2.4.1 Growing prevalence of obesity and CVD to drive market
TABLE 59 GLOBAL MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and growing focus on workplace drug testing to drive market
TABLE 60 GLOBAL MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.2.6 OTHER CLINICAL TESTS
TABLE 61 GLOBAL MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2020-2027 (USD MILLION)
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS, PARTICULARLY IN LARGE LIVESTOCK ANIMALS, TO DRIVE MARKET
TABLE 62 GLOBAL MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 FOOD SAFETY AND ENVIRONMENTAL TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE SUPPORTING MARKET GROWTH
TABLE 63 GLOBAL MARKET FOR FOOD SAFETY AND ENVIRONMENTAL TESTING, BY COUNTRY, 2020-2027 (USD MILLION)
7.5 DRUG DEVELOPMENT AND QUALITY TESTING
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET
TABLE 64 GLOBAL MARKET FOR DRUG DEVELOPMENT AND QUALITY TESTING, BY COUNTRY, 2020-2027 (USD MILLION)

8 LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE (Page No. - 145)
8.1 INTRODUCTION
TABLE 65 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 66 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.2 SANDWICH ASSAYS
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
TABLE 67 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY IN RELATION TO SANDWICH ASSAYS TO HAMPER GROWTH
TABLE 68 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET
TABLE 69 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE (Page No. - 152)
9.1 INTRODUCTION
TABLE 70 LATERAL FLOW ASSAY MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
9.2 BLOOD SAMPLES
9.2.1 INCREASING USE OF BLOOD SAMPLES IN INFECTIOUS DISEASE TESTING TO DRIVE MARKET
TABLE 71 GLOBAL MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2020-2027 (USD MILLION)
9.3 URINE SAMPLES
9.3.1 GROWING USE OF URINE SAMPLES IN PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET
TABLE 72 GLOBAL MARKET FOR URINE SAMPLES, BY COUNTRY, 2020-2027 (USD MILLION)
9.4 SALIVA SAMPLES
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
TABLE 73 GLOBAL MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2020-2027 (USD MILLION)
9.5 OTHER SAMPLES
TABLE 74 GLOBAL MARKET FOR OTHER SAMPLES, BY COUNTRY, 2020-2027 (USD MILLION)

10 LATERAL FLOW ASSAYS MARKET, BY END USER (Page No. - 158)
10.1 INTRODUCTION
TABLE 75 LATERAL FLOW ASSAY MARKET, BY END USER, 2020-2027 (USD MILLION)
10.2 HOSPITALS AND CLINICS
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET
TABLE 76 GLOBAL MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
10.3 HOME CARE SETTINGS
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
TABLE 77 GLOBAL MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020-2027 (USD MILLION)
10.4 DIAGNOSTIC LABORATORIES
10.4.1 HIGH PREFERENCE FOR LABORATORY TESTING TO TEST URINE AND BLOOD SAMPLES TO SUPPORT MARKET GROWTH
TABLE 78 GLOBAL MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020-2027 (USD MILLION)
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
TABLE 79 GLOBAL MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
10.6 OTHER END USERS
TABLE 80 GLOBAL MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

11 LATERAL FLOW ASSAYS MARKET, BY REGION (Page No. - 166)
11.1 INTRODUCTION
FIGURE 35 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 81 LATERAL FLOW ASSAY MARKET, BY REGION, 2020-2027 (USD MILLION)
11.2 NORTH AMERICA
TABLE 82 NORTH AMERICA: MACROECONOMIC INDICATORS
FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
TABLE 83 NORTH AMERICA: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 84 NORTH AMERICA: MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 85 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 86 NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 88 NORTH AMERICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.2.1 US
11.2.1.1 Largest market for lateral flow assays
TABLE 95 US: MACROECONOMIC INDICATORS
TABLE 96 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 97 US: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 98 US: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 99 US: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 100 US: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 101 US: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 102 US: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 103 US: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 104 US: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 105 US: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 106 US: MARKET, BY END USER, 2020-2027 USD MILLION)
11.2.2 CANADA
11.2.2.1 Availability of research funding and implementation of favorable government initiatives to drive market
TABLE 107 CANADA: MACROECONOMIC INDICATORS
TABLE 108 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 109 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 110 CANADA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 111 CANADA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 112 CANADA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 113 CANADA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 114 CANADA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 115 CANADA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 116 CANADA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 117 CANADA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 118 CANADA: MARKET, BY END USER, 2020-2027 USD MILLION)
11.2.3 RECESSION IMPACT
11.3 EUROPE
TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 120 EUROPE: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 121 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 122 EUROPE: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 123 EUROPE: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 124 EUROPE: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 125 EUROPE: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 126 EUROPE: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 127 EUROPE: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 128 EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 129 EUROPE: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 130 EUROPE: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Growing number of POC diagnostic centers to drive demand for lateral flow assays
TABLE 131 GERMANY: MACROECONOMIC INDICATORS
TABLE 132 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 133 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 134 GERMANY: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 135 GERMANY: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 136 GERMANY: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 137 GERMANY: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 138 GERMANY: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 139 GERMANY: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 140 GERMANY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 141 GERMANY: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 142 GERMANY: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 High prevalence of age-related chronic and infectious diseases to drive market
TABLE 143 FRANCE: MACROECONOMIC INDICATORS
TABLE 144 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 145 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 146 FRANCE: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 147 FRANCE: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 148 FRANCE: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 149 FRANCE: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 150 FRANCE: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 151 FRANCE: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 152 FRANCE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 153 FRANCE: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 154 FRANCE: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising prevalence of obesity to propel market
TABLE 155 UK: MACROECONOMIC INDICATORS
TABLE 156 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 157 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 158 UK: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 159 UK: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 160 UK: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 161 UK: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 162 UK: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 163 UK: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 164 UK: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 165 UK: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 166 UK: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Growing initiatives toward decentralization of medical services to support market growth
TABLE 167 ITALY: MACROECONOMIC INDICATORS
TABLE 168 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 169 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 170 ITALY: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 171 ITALY: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 172 ITALY: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 173 ITALY: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 174 ITALY: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 175 ITALY: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 176 ITALY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 177 ITALY: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 178 ITALY: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Increasing focus of international organizations and domestic players on development of POC products to aid market growth
TABLE 179 SPAIN: MACROECONOMIC INDICATORS
TABLE 180 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 181 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 182 SPAIN: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 183 SPAIN: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 184 SPAIN: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 185 SPAIN: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 186 SPAIN: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 187 SPAIN: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 188 SPAIN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 189 SPAIN: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 190 SPAIN: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 191 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 192 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 193 REST OF EUROPE: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 194 REST OF EUROPE: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 195 REST OF EUROPE: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 196 REST OF EUROPE: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 197 REST OF EUROPE: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 198 REST OF EUROPE: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 200 REST OF EUROPE: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 201 REST OF EUROPE: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.3.7 RECESSION IMPACT
11.4 ASIA PACIFIC
FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
TABLE 202 ASIA PACIFIC: LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 203 ASIA PACIFIC: MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 204 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 205 ASIA PACIFIC: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 206 ASIA PACIFIC: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 207 ASIA PACIFIC: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 208 ASIA PACIFIC: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 211 ASIA PACIFIC: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 212 ASIA PACIFIC: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 213 ASIA PACIFIC: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.1 CHINA
11.4.1.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development to drive market
TABLE 214 CHINA: MACROECONOMIC INDICATORS
TABLE 215 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 216 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 217 CHINA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 218 CHINA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 219 CHINA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 220 CHINA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 221 CHINA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 222 CHINA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 223 CHINA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 224 CHINA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 225 CHINA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Increasing prevalence of age-related illnesses to drive market
TABLE 226 JAPAN: MACROECONOMIC INDICATORS
TABLE 227 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 228 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 229 JAPAN: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 230 JAPAN: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 231 JAPAN: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 232 JAPAN: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 233 JAPAN: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 234 JAPAN: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 235 JAPAN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 236 JAPAN: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 237 JAPAN: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Growing healthcare concerns and rising income levels to propel market
TABLE 238 INDIA: MACROECONOMIC INDICATORS
TABLE 239 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 240 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 241 INDIA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 242 INDIA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 243 INDIA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 244 INDIA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 245 INDIA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 246 INDIA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 247 INDIA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 248 INDIA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 249 INDIA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive market
TABLE 250 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 251 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 252 AUSTRALIA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 253 AUSTRALIA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 254 AUSTRALIA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 255 AUSTRALIA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 256 AUSTRALIA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 257 AUSTRALIA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 258 AUSTRALIA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 259 AUSTRALIA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 260 AUSTRALIA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 261 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 262 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 263 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 264 REST OF ASIA PACIFIC: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 265 REST OF ASIA PACIFIC: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 266 REST OF ASIA PACIFIC: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 267 REST OF ASIA PACIFIC: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 268 REST OF ASIA PACIFIC: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 269 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 270 REST OF ASIA PACIFIC: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 271 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.4.6 RECESSION IMPACT
11.5 LATIN AMERICA
TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 273 LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 274 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 275 LATIN AMERICA: MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 276 LATIN AMERICA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 277 LATIN AMERICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 278 LATIN AMERICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 279 LATIN AMERICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 280 LATIN AMERICA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 281 LATIN AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 282 LATIN AMERICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 283 LATIN AMERICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 High healthcare expenditure and increasing geriatric population to drive market
TABLE 284 BRAZIL: MACROECONOMIC INDICATORS
TABLE 285 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 286 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 287 BRAZIL: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 288 BRAZIL: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 289 BRAZIL: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 290 BRAZIL: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 291 BRAZIL: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 292 BRAZIL: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 293 BRAZIL: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 294 BRAZIL: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 295 BRAZIL: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 High prevalence of obesity and related chronic diseases to propel market
TABLE 296 MEXICO: MACROECONOMIC INDICATORS
TABLE 297 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 298 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 299 MEXICO: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 300 MEXICO: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 301 MEXICO: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 302 MEXICO: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 303 MEXICO: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 304 MEXICO: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 305 MEXICO: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 306 MEXICO: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 307 MEXICO: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 308 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 309 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 310 REST OF LATIN AMERICA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 311 REST OF LATIN AMERICA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 312 REST OF LATIN AMERICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 313 REST OF LATIN AMERICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 314 REST OF LATIN AMERICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 315 REST OF LATIN AMERICA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 316 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 317 REST OF LATIN AMERICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 318 REST OF LATIN AMERICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.5.4 RECESSION IMPACT
11.6 MIDDLE EAST & AFRICA
11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARD EXPANSION OF HEALTHCARE SERVICES TO DRIVE MARKET
TABLE 319 AFRICA: MACROECONOMIC INDICATORS
TABLE 320 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 321 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 322 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 323 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 324 MIDDLE EAST & AFRICA: MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 325 MIDDLE EAST & AFRICA: MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020-2027 (USD MILLION)
TABLE 326 MIDDLE EAST & AFRICA: MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 327 MIDDLE EAST & AFRICA: MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020-2027 (USD MILLION)
TABLE 328 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
TABLE 329 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020-2027 (USD MILLION)
TABLE 330 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020-2027 (USD MILLION)
11.6.2 RECESSION IMPACT

12 COMPETITIVE LANDSCAPE (Page No. - 278)
12.1 OVERVIEW
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 38 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET
12.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN GLOBAL MARKET
12.4 MARKET SHARE ANALYSIS
FIGURE 40 LATERAL FLOW ASSAY MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
12.5 R&D ASSESSMENT OF KEY PLAYERS
FIGURE 41 R&D EXPENDITURE: MAJOR PLAYERS IN GLOBAL MARKET, 2020 VS. 2021
12.6 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
12.6.1 STARS
12.6.2 PERVASIVE PLAYERS
12.6.3 EMERGING LEADERS
12.6.4 PARTICIPANTS
FIGURE 42 GLOBAL MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021
12.7 COMPANY EVALUATION QUADRANT FOR SMES AND STARTUPS
12.7.1 PROGRESSIVE COMPANIES
12.7.2 DYNAMIC COMPANIES
12.7.3 STARTING BLOCKS
12.7.4 RESPONSIVE COMPANIES
FIGURE 43 GLOBAL MARKET: COMPANY EVALUATION MATRIX FOR SMES AND STARTUPS, 2021
12.8 COMPETITIVE BENCHMARKING
12.8.1 COMPANY FOOTPRINT ANALYSIS
TABLE 332 OVERALL COMPANY FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 333 PRODUCT FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 334 TECHNIQUE FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 335 APPLICATION FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 336 SAMPLE TYPE FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 337 END-USER FOOTPRINT ANALYSIS (25 COMPANIES)
TABLE 338 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES)
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 339 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019-DECEMBER 2022
12.9.2 DEALS
TABLE 340 DEALS, JANUARY 2019-DECEMBER 2022
12.9.3 OTHER DEVELOPMENTS
TABLE 341 OTHER DEVELOPMENTS, JANUARY 2019-DECEMBER 2022

13 COMPANY PROFILES (Page No. - 298)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
13.1 KEY PLAYERS
13.1.1 ABBOTT LABORATORIES
TABLE 342 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
13.1.2 F. HOFFMANN-LA ROCHE LTD.
TABLE 343 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
13.1.3 QUIDEL CORPORATION
TABLE 344 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 46 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
13.1.4 DANAHER CORPORATION
TABLE 345 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
13.1.5 SIEMENS AG
TABLE 346 SIEMENS AG: BUSINESS OVERVIEW
FIGURE 48 SIEMENS AG: COMPANY SNAPSHOT (2021)
13.1.6 BECTON, DICKINSON AND COMPANY
TABLE 347 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 49 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
13.1.7 BIOMÉRIEUX SA
TABLE 348 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 50 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
13.1.8 THERMO FISHER SCIENTIFIC INC.
TABLE 349 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 51 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
13.1.9 PERKINELMER INC.
TABLE 350 PERKINELMER INC.: BUSINESS OVERVIEW
FIGURE 52 PERKINELMER INC.: COMPANY SNAPSHOT (2021)
13.1.10 QIAGEN N.V.
TABLE 351 QIAGEN N. V.: BUSINESS OVERVIEW
FIGURE 53 QIAGEN N. V.: COMPANY SNAPSHOT (2021)
13.2 OTHER PLAYERS
13.2.1 MERCK KGAA
TABLE 352 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 54 MERCK KGAA: COMPANY SNAPSHOT (2021)
13.2.2 HOLOGIC, INC.
TABLE 353 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 55 HOLOGIC, INC.: COMPANY SNAPSHOT (2021)
13.2.3 ABCAM PLC
TABLE 354 ABCAM PLC: BUSINESS OVERVIEW
FIGURE 56 ABCAM PLC: COMPANY SNAPSHOT (2021)
13.2.4 SURMODICS, INC.
TABLE 355 SURMODICS, INC.: BUSINESS OVERVIEW
FIGURE 57 SURMODICS, INC.: COMPANY SNAPSHOT (2021)
13.2.5 CHEMBIO DIAGNOSTICS, INC.
TABLE 356 CHEMBIO DIAGNOSTICS, INC.: BUSINESS OVERVIEW
FIGURE 58 CHEMBIO DIAGNOSTICS, INC.: COMPANY SNAPSHOT (2021)
13.2.6 ORASURE TECHNOLOGIES
TABLE 357 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 59 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2021)
13.2.7 DCN DIAGNOSTICS
TABLE 358 DCN DIAGNOSTICS: BUSINESS OVERVIEW
13.2.8 POLYSCIENCES INC.
TABLE 359 POLYSCIENCES INC.: BUSINESS OVERVIEW
13.2.9 ABINGDON HEALTH
TABLE 360 ABINGDON HEALTH: BUSINESS OVERVIEW
13.2.10 ORANOXIS INC.
TABLE 361 ORANOXIS INC.: BUSINESS OVERVIEW
13.2.11 AESKU.GROUP GMBH
TABLE 362 AESKU.GROUP GMBH: BUSINESS OVERVIEW
13.2.12 BIO GROUP MEDICAL SYSTEM S.R.L
TABLE 363 BIO GROUP MEDICAL SYSTEM S.R.L: BUSINESS OVERVIEW
13.2.13 PHARMACT GMBH
TABLE 364 PHARMACT GMBH: BUSINESS OVERVIEW
13.2.14 DIESSE DIAGNOSTICA SENESE S.P.A.
TABLE 365 DIESSE DIAGNOSTICA SENESE S.P.A.: BUSINESS OVERVIEW
13.2.15 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
TABLE 366 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 366)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS